Company: CRL
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001100682-25-000011
Chunk: 129

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 129
---
 617,261 650,975 Other income (expense)   Interest income8,575 5,196 780 Interest expense(126,288)(136,710)(59,291)Other income (expense), net(16,520)95,537 30,523 Income before income taxes93,114 581,284 622,987 Provision for income taxes67,823 100,914 130,379 Net income25,291 480,370 492,608 Less: Net income attributable to noncontrolling interests3,088 5,746 6,382 Net income attributable to Charles River Laboratories International Inc.$22,203 $474,624 $486,226 Calculation of net income per share attributable to Charles River Laboratories International Inc. common shareholdersNet income attributable to Charles River Laboratories International Inc.$22,203 $474,624 $486,226 Less: Incremental dividends attributed to noncontrolling interest holders11,906 — — Net income available to Charles River Laboratories International Inc. common shareholders$10,297 $474,624 $486,226 Earnings per common share   Basic$0.20 $9.27 $9.57 Diluted$0.20 $9.22 $9.48 Weighted-average number of common shares outstandingBasic51,380 51,227 50,812 Diluted51,628 51,451 51,301 See Notes to Consolidated Financial Statements.

59

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)(in thousands)

Fiscal Year202420232022Net income$25,291 $480,370 $492,608 Other comprehensive income (loss):Foreign currency translation adjustment(130,112)70,651 (129,091)Pension and other post-retirement benefit plans (Note 14):Prior service cost and (losses) gains arising during the period(12,190)(5,376)24,471 Amortization of net loss, settlement losses, and prior service benefit included in total cost for pension and other post-retirement benefit plans1,596 736 3,337 Unrealized gains (losses) on hedging instruments(966)2,490 (1,523)Other